| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS30013706 | HIV | ENSG00000086062.14 | protein_coding | B4GALT1 | No | No | 2683 | P15291 |
| TVIS30079750 | HIV | ENSG00000086062.14 | protein_coding | B4GALT1 | No | No | 2683 | P15291 |
| TVIS20063902 | HPV | ENSG00000086062.14 | protein_coding | B4GALT1 | No | No | 2683 | P15291 |
| TVIS44005723 | HTLV-1 | ENSG00000086062.14 | protein_coding | B4GALT1 | No | No | 2683 | P15291 |
| TVIS44017072 | HTLV-1 | ENSG00000086062.14 | protein_coding | B4GALT1 | No | No | 2683 | P15291 |
| TVIS44017073 | HTLV-1 | ENSG00000086062.14 | protein_coding | B4GALT1 | No | No | 2683 | P15291 |
| TVIS44040312 | HTLV-1 | ENSG00000086062.14 | protein_coding | B4GALT1 | No | No | 2683 | P15291 |
| TVIS44040311 | HTLV-1 | ENSG00000086062.14 | protein_coding | B4GALT1 | No | No | 2683 | P15291 |
| TVIS44040078 | HTLV-1 | ENSG00000086062.14 | protein_coding | B4GALT1 | No | No | 2683 | P15291 |
| TVIS44040186 | HTLV-1 | ENSG00000086062.14 | protein_coding | B4GALT1 | No | No | 2683 | P15291 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | B4GALT1 |
|---|---|
| DrugBank ID | DB03685 |
| Drug Name | Uridine monophosphate |
| Target ID | BE0000259 |
| UniProt ID | P15291 |
| Regulation Type | |
| PubMed IDs | 17139284; 17016423; 10592235 |
| Citations | Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.@@Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.@@Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. |
| Groups | Experimental |
| Direct Classification | Pyrimidine ribonucleoside monophosphates |
| SMILES | O[C@H]1[C@@H](O)[C@@H](O[C@@H]1COP(O)(O)=O)N1C=CC(=O)NC1=O |
| Pathways | Clomocycline Action Pathway; Rolitetracycline Action Pathway; Dihydropyrimidinase Deficiency; Lactose Synthesis; Demeclocycline Action Pathway; Josamycin Action Pathway; Gentamicin Action Pathway; Kanamycin Action Pathway; Tobramycin Action Pathway; MNGIE (Mitochondrial Neurogastrointestinal Encephalopathy); Azithromycin Action Pathway; Clarithromycin Action Pathway; beta-Ureidopropionase Deficiency; UMP Synthase Deficiency (Orotic Aciduria); Troleandomycin Action Pathway; Amikacin Action Pathway; Streptomycin Action Pathway; Pyrimidine Metabolism; Congenital Disorder of Glycosylation CDG-IId; Oxytetracycline Action Pathway; Tetracycline Action Pathway; Spectinomycin Action Pathway; Erythromycin Action Pathway; Netilmicin Action Pathway; Doxycycline Action Pathway; Telithromycin Action Pathway; Neomycin Action Pathway; Roxithromycin Action Pathway; Arbekacin Action Pathway; Clindamycin Action Pathway |
| PharmGKB | |
| ChEMBL | CHEMBL214393 |
